Hepatitis B virus infection and intrahepatic cholangiocarcinoma

来源 :World Journal of Gastroenterology | 被引量 : 0次 | 上传用户:snesw
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Intrahepatic cholangiocarcinoma(ICC)is a devastating malignant tumor arising from the peripheral intrahepatic bile duct epithelium.The incidence and mortality of ICC is markedly increasing over the past two decades worldwide,though the cause for this rise in incidence is unclear,thus intensifying the search for alternative etiological agents and pathogenetic mechanisms.Hepatolithiasis,primary sclerosing cholangitis,parasitic infection(Opisthorchis viverrini or Clonorchis sinensis),fibropolycystic liver disease,and chemical carcinogen exposure are thought to be the risk factors for ICC.Nevertheless,the majority of ICC patients do not have any of these risk factors,and none of the established risk factors can explain the recent increasing trend of ICC.Therefore,identifying other risk factors may lead to the prevention and early detection of ICC.Chronic hepatitis B virus(HBV)infection is the predominant cause of hepatocellular carcinoma in HBVendemic areas.This review discusses the evidence implicating chronic HBV infection as a likely etiology of ICC and the pathogenetic mechanisms that might be involved. Intrahepatic cholangiocarcinoma (ICC) is a devastating malignant tumor arising from the peripheral intrahepatic bile duct epithelium. The incidence and mortality of ICC is markedly increasing over the past two decades worldwide, though the cause for for rise in incidence is unclear, thus intensifying the search for alternative etiological agents and pathogenetic mechanisms. Hepatatolithiasis, primary sclerosing cholangitis, parasitic infection (Opisthorchis viverrini or Clonorchis sinensis), fibropolycystic liver disease, and chemical carcinogen exposure are thought to be the risk factors for ICC. However, the majority of ICC patients do not have any of these risk factors, and none of the established risk factors can explain the recent increasing trend of ICC.Therefore, identifying other risk factors may lead to the prevention and early detection of ICC. Chronic hepatitis B virus (HBV) infection is the predominant cause of hepatocellular carcinoma in HBVendemic areas. This review discusses the eviden ce implicating chronic HBV infection as a likely etiology of ICC and the pathogenetic mechanisms that might be involved.
其他文献
自古以来,中医对中药的煎法及服法是非常重要的,同样一张药方,因为药物的煎法、服法不同,治疗的适应证和效果就不一样,一个病即便辨证再准确,用药再恰当,如果煎、服方法不当,
期刊
说起呼吸衰竭,想必大家应该都不陌生吧,简单的说多种疾病都可以引发患者出现呼吸衰竭的现象,这种病状是临床中比较常见的内科疾病.呼吸衰竭的主要特征就是病情发展的加快,而
期刊
目的:探讨参芪温元方联合针刺治疗甲减的应用及疗效分析.方法:将2018年6月-2019年6月在我院治疗的92例甲状腺功能减退症患者随机分为两组,对照组使用左旋甲状腺素片治疗,观察
目的:探究大承气汤灌肠与有创机械通气联合治疗慢性阻塞性肺疾病呼吸衰竭患者的临床效果.方法:选取2017年1月至2019年1月时间段至我院就诊的60例慢性阻塞性肺疾病呼吸衰竭患
目的 探究中医辨证治疗脑梗塞对患者脑神经功能的效果.方法 涉及对象为脑梗塞者80例,开始时间为2019年1月,结束时间为2019年10月,其中40例患者实施西医治疗,视为参照组,40例
目的 探究针灸推拿对中风后痉挛性瘫痪患者康复治疗的效果.方法 选取中风后痉挛性瘫痪患者78例,研究时间为2018年12月-2019年12月,分为参照组与研究组,每组各39例,给予参照组
马尔可夫决策过程(MDP)的许多优化算法一般依赖系统的转移速率,而系统参数的不确定性使得MDP的转移速率往往很难精确得知。针对一类不确定多链MDP模型,基于性能势对参数不相
目的:探讨参芪温元方联合针刺对甲减的治疗作用研究.方法:将2018年6月-2019年6月在我院治疗的92例甲状腺功能减退症患者按数字分组法平均分为两组,对照组使用左旋甲状腺素片
目的:观察补肾活血方联合戈舍瑞林治疗子宫内膜异位症合并不孕的效果.方法:选取2018年1月-2019年1月收治的88例子宫内膜异位症合并不孕患者为研究对象,随机分为实验组和对照
目的:探究宣白承气汤加减治疗痰热壅肺型重症肺炎的临床疗效.方法:本次研究观察对象设定为70名,于研究期内(2018年6月-次年5月)从我院收治的痰热壅肺型重症肺炎患者中筛取,所